OmanDocSign in

Curriculum · Metabolic and Endocrine and Diabetes Mellitus

Hyperprolactinaemia

What it is

Hyperprolactinemia is a high prolactin level. Dopamine normally inhibits prolactin secretion in the pituitary gland, so a tumor that makes prolactin, and a drug that blocks that dopamine, end in the same place. The hormonal changes run together: prolactin up, LH and FSH down, and with them testosterone and estrogen, and each of these hormonal changes has its own features in the female and in the male. That is why the clinical features are as much features of low testosterone and low estrogen as they are of prolactin itself.

Causes and risk

The antipsychotics are named as a group and not only by one drug: many antipsychotic medications, through hypothalamic dopamine blockade, are associated with an increased risk for hyperprolactinemia. It can be asymptomatic, but it can also lead to gynecomastia and to infertility, sexual dysfunction, and in women irregular menses. A 24 year old man with schizophrenia stabilized on an antipsychotic who presents with gynecomastia has hyperprolactinemia as the most likely cause, rather than persistent pubertal gynecomastia, an increased estrogen level, an elevated cortisol level or a pituitary adenoma.

How it presents

In premenopausal women: galactorrhea, oligo/amenorrhea or irregular menses, anovulation and infertility, decreased libido, dyspareunia, vaginal dryness, hot flashes, decreased bone density and the risk of osteoporosis, which comes after several years, and an atrophic endometrium with vaginal atrophy, which are menopausal symptoms.

In postmenopausal women what shows is the mass effect: headache and visual field defects, with parasellar signs and symptoms less common than in men.

In men: infertility, loss of libido, erectile dysfunction and impotence, gynecomastia, reduced facial and body hair, and osteoporosis. Galactorrhea is rare in men, and there may be little to no noticeable effects. Parasellar signs and symptoms, the mass effects of the tumor, are more prevalent in men than in women, largely because the early symptoms in men, such as impotence, are often attributed to psychological causes and medical evaluation is delayed, which allows for larger tumor growth.

It turns up in three other lists worth holding. In the history taken for abnormal uterine bleeding, headache with visual disturbance and galactorrhea is the set that points to hyperprolactinemia, as hirsutism with acne and weight gain points to PCOS. Among the causes of secondary amenorrhoea it stands with pregnancy, hypogonadotropic hypogonadism, hyperthyroidism, hypoglycemia, carcinoid and pheochromocytoma, and for menstrual cycle changes the differential is pregnancy, hyperprolactinemia and thyroid disease. In infertility it is one of the hypothalamic-pituitary factors in either sex, beside hypopituitarism, and in delayed puberty it is one of the functional gonadotropin deficiencies causing hypogonadotropic hypogonadism, with chronic systemic disease and malnutrition, hypothyroidism, Cushing disease, diabetes mellitus, anorexia nervosa and psychogenic amenorrhea; prolactinoma itself is on the same page among the CNS tumors, with craniopharyngioma, germinoma and glioma.